Infertility

I wish it were that simple.

You aren't looking at all the causes of You also don't account for human behaviour." Moreover, medicare covers in-lab fertility tests, making the cost all the more absurd, Rowe says.Thompson says physicians are right to be skeptical - "there's a lot of crap put out there" - but notes the male device was written up in Human Reproduction, Oxford University's well-regarded journal of reproductive sciences.

The article pointed out the value of privacy: producing a semen sample in a doctor's office can be an embarrassing, humiliating and sometimes futile experience.

"We identify some major contributors to The woman has it easy: on the third day of her cycle, she pees on the stick and waits half an hour.

It measures the follicle-stimulating hormone (FSH), which is an indicator of ovarian reserve.

The FSH measure is commonly used in menopausal tests, though Fertell is the first to be calibrated for fertility, according to Thompson.

If a single red line - or a second lighter line - appears, all is swell.

A darker second line means .

.

.

wel...

Halozyme's recombinant human enzymes may replace current animal slaughterhouse-derived extracts that carry potential risks of animal pathogen transmission and immunogenicity.

The company has received FDA approval for two products: Cumulase(TM), the first and only recombinant human hyaluronidase for cumulus removal in the IVF process; and Hylenex(TM), for use as an adjuvant to increase the absorption and dispersion of other injected drugs.

The versatility of the first enzyme, rHuPH20, enables Halozyme to develop the product as a medical device, drug enhancement agent, and therapeutic drug.

Halozyme Contact Investor Relations Contacts David A.

Ramsay Zachary Bryant Chief Financial Officer Lippert/Heilshorn & Associates (858) 794-8889 (310) 691-7100 dramsay@halozyme.com zbryant@lhai.com CONTACT: David A.

Ramsay, Chief Financial Officer of HalozymeTherapeutics, Inc., +1-858-794-8889, ; or InvestorRelations, Zachary Bryant of Lippert/Heilshorn & Associates,+1-310-691-7100, , for Halozyme Therapeutics, Inc.

dramsay@halozyme.com zbryant@lhai.com Web site: http://www.halozyme.com/ Ticker Symbol: (AMEX:HTI) Terms and conditions of use applyCopyright © 2006 PR Newswire Association LLC.

All rights reserved.A United Business Media Co...